Optional Friday Courses
What’s New in GI Pharmacology Course
Friday, October 3 · 1:45 pm - 4:45 pm
Course Director: Philip O. Katz, MD, FACG
Part of the 3-Day Board Review
Program Description
There is an ever-increasing demand on a physician’s time to keep up with the expanding list of pharmacologic treatments of GI and liver disorders. ACG’s What’s New in Pharmacology Course provides an intensive review of key GI pharmacology, including comparisons and contrasts between conventional and emerging pharmacological treatment options. A comprehensive review of hot topic areas such as eosinophilic esophagitis, IBD, hepatic encephalopathy, NSAIDs, functional bowel disorders, and GI medications in pregnancy will be conducted in didactic presentations from expert faculty. The program is designed primarily for clinicians in GI/hepatology as well as physician assistants, nurse practitioners and other advanced practice healthcare professionals interested in the latest information on state of the art treatment of these illnesses.
Program Objectives
- Describe current and emerging therapeutic strategies for patients diagnosed with eosinophilic esophagitis.
- Select management strategies to minimize the gastroenterological risks associated with NSAID use.
- Review the evidence regarding the efficacy and safety profile of current pharmacologic and biologic therapies in the management of IBD.
- Identify the most effective pharmacological treatment options for the management of predominant symptoms of functional bowel disorders.
- Evaluate pharmacological therapies for the management of hepatic encephalopathy.
- Determine available pharmacological therapies that are safe and effective, and those to be avoided, for treatment of GI disorders in the pregnant patient.
Agenda
| 1:45 pm |
Eosinophilic Esophagitis: Current Therapies and Future Directions
Joel E. Richter, MD, MACG |
| 2:15 pm |
NSAIDs: The Good, the Bad, the Ugly
James M. Scheiman, MD, FACG |
| 2:45 pm |
What’s New for IBD
Sunanda V. Kane, MD, MSPH, FACG |
| 3:15 pm |
Pharmacological Management of Symptoms in the Functional Bowel Disorders
Lawrence R. Schiller, MD, FACG |
| 3:45 pm |
Management of Hepatic Encephalopathy: Starvation Diet No Longer Required
Mitchell L. Shiffman, MD, FACG |
| 4:15 pm |
GI Medications in Pregnancy
Philip O. Katz, MD, FACG |
| 4:45 pm |
Adjourn |
Accreditation
The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American College of Gastroenterology designates these educational activities for a maximum 3 AMA PRA Category 1 Credits™. Each physician should claim credit commensurate with the extent of their participation in the activity.
|
